Cuba’s COVID-19 Vaccine Enterprise: Report from a High-Level Fact-Finding Delegation to Cuba

Michael T. Osterholm, Cristina Rabadán-Diehl, Joshua Anzinger, Maria Elena Bottazzi, Celia Christie-Samuels, Ngozi Erondu, Jeanne Marrazzo, Sandra Milan, Peter Kojo Quashie, Thomas Schwaab, David Williams

Research output: Contribution to journalArticlepeer-review

5 Citations (Scopus)

Abstract

In June 2022 an international delegation of scientists from the United States, the Caribbean and Africa traveled to Havana, Cuba for a three-day fact-finding mission to better understand Cuba’s COVID-19 vaccine development and vaccination efforts. It was the first time in five years that a scientific delegation with significant US presence had engaged in discussions with medical researchers in Cuba. It also included African and Caribbean members to ensure there was a diversity of scientific and public health perspectives. Together, delegation members represented a broad range of expertise in public health systems, infectious diseases, biotechnology, and vaccine development.

Original languageEnglish
JournalMEDICC Review
Volume24
Issue number3-4
DOIs
Publication statusPublished - Jul 2022

Fingerprint

Dive into the research topics of 'Cuba’s COVID-19 Vaccine Enterprise: Report from a High-Level Fact-Finding Delegation to Cuba'. Together they form a unique fingerprint.

Cite this